The R&D head is looking for "clever science," which Friberg said is readily apparent in BioMarin’s recent research pact with CAMP4 Therapeutics. The partners are using CAMP4’s regulatory RNA platform ...
As the U.S. stock market experiences fluctuations with major indexes like the Dow Jones and S&P 500 facing potential weekly losses, investors are increasingly focusing on identifying resilient growth ...
CHARLOTTE, N.C., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Magnera (NYSE: MAGN) will present at JP Morgan’s Global Leveraged Finance Conference in Miami Beach, Florida. Magnera CEO, Curt Begle, and CFO & ...